“An IgG-guided elimination diet improves IBS symptoms.”
An IgG-guided elimination diet eased IBS symptoms modestly in two trials, more than a fake diet that removed other foods.
An IgG-guided diet helped somewhat more people with IBS than a fake diet in two trials, but the gain was modest, and the test behind it does not diagnose food intolerance. IBS guidelines do not recommend IgG-based diets. The diet they back is low-FODMAP, done in steps with a trained professional after general diet advice has not been enough.
If your IBS symptoms seem tied to food, ask your clinician about a low-FODMAP diet guided by a dietitian before you pay for an IgG test.
Talk to a healthcare professional if: you have IBS and are thinking about cutting out several foods at once, you have had an eating disorder, or you have trouble getting enough food.
Two sham-controlled trials found more relief on IgG-guided diets than on fake diets, so the claim holds in people with IBS. Confidence is limited because the gain was modest, the larger trial was funded by the test maker, and in the earlier trial the guided diet most often cut milk and wheat, so the benefit may come from those foods rather than from the test.
An IgG-guided elimination diet eased IBS symptoms modestly in two trials, more than a fake diet that removed other foods. In the larger 2025 trial, 60% of people on the guided diet had at least a 30% drop in belly pain for 2 of the last 4 weeks, compared with 42% on the fake diet. That works out to about 17 or 18 more people out of every 100. The trial was funded by Biomerica, the company that makes the test, and at least two of its authors consult for the company. The 2004 trial used a different IgG test and was run by university researchers, with the testing company running the tests and writing the diet sheets. In that trial, symptom scores fell 10% more on the true diet than on the fake one, and more people quit the true diet (24 vs 13), mostly because it was hard to follow. These results do not show that IgG tests diagnose food intolerance. Many people on the fake diets also improved, and no trial has compared an IgG-guided diet with the low-FODMAP diet that IBS guidelines recommend.
The 2025 trial enrolled adults with IBS at 8 centers who tested positive for at least 1 of 18 foods on an IBS-specific IgG test. Of 238 people randomized, 223 were analyzed after 8 weeks. Neither the patients nor the study staff knew who had the real diet, and the fake diet cut the same number of foods, just not the ones the test flagged. The trial's public registry lists a different main measure, the change in daily belly pain, from the responder measure the paper reports. Benefit looked largest in people with constipation-type and mixed-type IBS, but those were smaller subgroups. In the 2004 trial, the true diet most often cut yeast, milk, egg, wheat and cashews, while the fake diet most often cut potato, rice and tomato. Milk and wheat are common IBS triggers, so the trials cannot tell whether the test found each person's problem foods or simply steered people away from common ones. The British Society of Gastroenterology (2021) strongly recommends against IgG-based elimination diets for IBS, citing a modest benefit and concerns that the test flags many foods that do not cause symptoms; for example, 87% of patients in the 2004 trial had IgG to yeast, which rarely causes symptoms. The American College of Gastroenterology (2021) advises against routine food allergy and food sensitivity testing in IBS unless a person has repeated reactions that suggest a true food allergy, and it recommends a limited trial of a low-FODMAP diet. The American Gastroenterological Association calls low-FODMAP the diet with the most evidence for IBS. The British guideline also backs it, as a second-line step after general diet advice, with supervision by a trained dietitian. Low-FODMAP means cutting back for a few weeks on certain carbs that ferment in the gut, then adding foods back one at a time to find personal triggers. All three sets of guidance were written before the 2025 trial was published.
- Singh P, Chey WD, Takakura W, Cash BD, Lacy BE, Quigley EMM, Randall CW, Lembo A. A Novel, IBS-Specific IgG ELISA-Based Elimination Diet in Irritable Bowel Syndrome: A Randomized, Sham-Controlled Trial. Gastroenterology. 2025;168(6):1128-1136.e4. DOI: 10.1053/j.gastro.2025.01.223. PMID: 39894284
- Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut. 2004;53(10):1459-1464. DOI: 10.1136/gut.2003.037697. PMID: 15361495. PMCID: PMC1774223
- Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, Agrawal A, Aziz I, Farmer AD, Eugenicos MP, Moss-Morris R, Yiannakou Y, Ford AC. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70(7):1214-1240. DOI: 10.1136/gutjnl-2021-324598. PMID: 33903147
- Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116(1):17-44. DOI: 10.14309/ajg.0000000000001036. PMID: 33315591
- Chey WD, Hashash JG, Manning L, Chang L. AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review. Gastroenterology. 2022;162(6):1737-1745.e5. DOI: 10.1053/j.gastro.2021.12.248. PMID: 35337654